sotorasib,docetaxel
amgen,mirati,sanofi,aventis
['lumakras', 'docetaxel', 'codebreak-200', '$amgn', '$mrtx']
$amgn lumakras disappoints a second time: os curves favour docetaxel, two discontinuations owing to drug-induced liver injury. my take on codebreak-200, being presented at #esmo22 presidential session now -&gt; $mrtx
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.